INSERM and its Midi-Pyrnes/Limousin directorate headed by Armelle Barelli will be responsible for budget management for all the project's clinical trials.
ECRIN (European Clinical Research Infrastructures Network) coordinated by INSERM and headed by Professor Jacques Demotes, is an infrastructure whose purpose is to facilitate the setting up of international trials in Europe. ECRIN will be responsible for the management of the project's clinical trials through its European partners, ensuring coordination between the various national networks.
Dr Laurent Abel (INSERM U980 "Human genetics of infectious diseases"), another French member of the consortium, will participate in the identification in humans of genetic markers affecting the susceptibility/resistance to bacterial infection and the response to their treatment, along with the other partners.
Two French networks will also participate in clinical trials for the COMBACTE project, the Rseau National de Recherche Clinique en Infectiologie (RENARCI) coordinated by Professor Bruno Hoen (Besanon University Hospital), with the support of the Institut Thmatique Multi-Organismes "Microbiologie et Maladies Infectieuses" (IMMI) directed by Professor Jean-Franois Delfraissy, and the CRICS (Clinical Research in Intensive Care and Sepsis) network, headed by Dr Bruno Franois and Professor Pierre-Franois Dequin at the Tours University Hospital. The Groupe pour la Recherche et l'Enseignement en Pneumo-Infectiologie (a Working Party emanating from the Socit de Pneumologie de Langue Franaise) coordinated by Professor Anne Bergeron at the AP-HP Saint-Louis with the collaboration of Dr Muriel Fartoukh at the APHP Tenon will be associated with the CRICS network.
COMBACTE, a unique excellence project with international visibility
COMBACTE is the European public/private partnership set up for the development of drugs.
The development of new
|Contact: Elodie PFENDER |
INSERM (Institut national de la sant et de la recherche mdicale)